|
2016
|
Invention
|
Process. There is described a process for the preparation of a stereospecific form of flurbiprofe... |
|
2015
|
Invention
|
Process for the manufacture of s-(+)-flurbiprofen. There is described a process for the preparati... |
|
2013
|
Invention
|
Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbi... |
|
2011
|
Invention
|
Efficient and cost-effective process for the manufacture of amyl m-cresol. There is described a p... |
|
|
Invention
|
Antiseptic chewing gum. There is described a chewing gum composition comprising a therapeutically... |
|
2009
|
Invention
|
Drug substance preparations, pharmaceutical compositions and dosage forms. The invention relates ... |
|
|
Invention
|
Process for the manufacture of racemic 2-aryl-propionic acid.
There is described a process for t... |
|
|
Invention
|
Process for the manufacture of racemic 2-aryl-propionic acid. There is described a process for th... |
|
2003
|
Invention
|
Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyr... |
|
2001
|
Invention
|
Stable pharmaceutical dosage form for paroxetin anhydrate. Medicaments in the form of soft gelati... |
|
|
Invention
|
Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyr... |
|
1999
|
Invention
|
Process for preparing an intermediate in the production of paroxetine. in which R.sub.1 is as def... |
|
1995
|
Invention
|
Process of resolving phenylpropionic acids using .alpha.-methylbenzylamine. A process for the pro... |
|
1993
|
Invention
|
Process of resolving phenylpropionic acids using alpha-methylbenzylamine. A process is disc... |
